药理学。一种黑马阿尔茨海默病药物令人费解的兴衰。 - Suppr

Suppr

超能文献

Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug.

作者信息

Miller Greg

出版信息

Science. 2010 Mar 12;327(5971):1309. doi: 10.1126/science.327.5971.1309.

DOI:10.1126/science.327.5971.1309

PMID:20223954

Abstract

摘要

相似文献

Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug.

Science. 2010 Mar 12;327(5971):1309. doi: 10.1126/science.327.5971.1309.

Symptomatic AD treatment fails in first phase III.

Nat Rev Drug Discov. 2016 Nov 3;15(11):738. doi: 10.1038/nrd.2016.225.

Partnership between academia and industry for drug discovery in Alzheimer's disease.

Alzheimers Dement. 2008 Mar;4(2):80-8. doi: 10.1016/j.jalz.2008.02.004.

New drug treatment for Alzheimer's disease. Information from unpublished trials should be made available.

BMJ. 1998 Oct 3;317(7163):946.

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

Pharmacogenomics J. 2007 Feb;7(1):10-28. doi: 10.1038/sj.tpj.6500397. Epub 2006 Jun 13.

Progress in Alzheimer's disease drug discovery: an update.

Curr Opin Investig Drugs. 2009 Jan;10(1):23-34.

Vaccine tests key Alzheimer's disease hypothesis.

Nat Biotechnol. 2001 Feb;19(2):104-5. doi: 10.1038/84340.

New treatments in the pipeline for Alzheimer's.

Johns Hopkins Med Lett Health After 50. 2009 May;21(3):4-5.

Hope in Alzheimer's fight emerges from unexpected places.

Nat Med. 2008 Sep;14(9):894. doi: 10.1038/nm0908-894.

Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.

IDrugs. 2007 Feb;10(2):121-33.

引用本文的文献

Exposure of Mesenchymal Stem Cells to an Alzheimer's Disease Environment Enhances Therapeutic Effects.

Stem Cells Int. 2021 Mar 16;2021:6660186. doi: 10.1155/2021/6660186. eCollection 2021.

Effects of mesenchymal stem cells transplantation on cognitive deficits in animal models of Alzheimer's disease: A systematic review and meta-analysis.

Brain Behav. 2018 Jul;8(7):e00982. doi: 10.1002/brb3.982. Epub 2018 Jun 6.

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.

J Alzheimers Dis. 2016;50(3):895-905. doi: 10.3233/JAD-150790.

GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.

Stem Cells Dev. 2015 Oct 15;24(20):2378-90. doi: 10.1089/scd.2014.0487. Epub 2015 Aug 19.

Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine).

Mol Neurobiol. 2015 Oct;52(2):970-8. doi: 10.1007/s12035-015-9249-4. Epub 2015 Jun 30.

Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities.

Neurotherapeutics. 2015 Jan;12(1):66-80. doi: 10.1007/s13311-014-0324-8.

Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.

Neurochem Res. 2014 Oct;39(10):1914-23. doi: 10.1007/s11064-014-1250-1. Epub 2014 Feb 4.

Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition.

BMC Med. 2013 Nov 19;11:246. doi: 10.1186/1741-7015-11-246.

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.

Transl Psychiatry. 2013 Oct 22;3(10):e317. doi: 10.1038/tp.2013.92.

Umbilical cord blood mesenchymal stem cells protect amyloid-β42 neurotoxicity via paracrine.

World J Stem Cells. 2012 Nov 26;4(11):110-6. doi: 10.4252/wjsc.v4.i11.110.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验